EffRx Pharmaceuticals SA announced today that Mission Pharmacal, San Antonio, Texas, has entered into a patent and technology licensing agreement with EffRx Pharmaceuticals SA, Freienbach, Switzerland, for the manufacturing and commercialization of BINOSTO^®(alendronate sodium) Effervescent Tablets in the United States and Canada. click here to read more